BP's £6 billion Castrol sale could trigger a domino effect as other energy majors look to unlock value from their chemical divisions. Early positioning could capture this trend.
Infrastructure funds are actively seeking stable, cash-generating chemical businesses like lubricants and coatings that offer defensive returns in any market environment.
These specialty chemical assets often trade at discounts within larger conglomerates, but strategic sales could reveal their true standalone value to the market.
This basket's total market capitalisation is 919,387.0440000002. Its profile is heavily anchored by a few very large-cap constituents, giving it a generally stable, broad-market orientation.
XOM: $502.31B
CVX: $302.07B
VVV: $3.83B
BP's recent sale of its Castrol lubricants business for $10.1 billion signals a broader trend where energy majors are divesting stable, cash-generating chemical assets. This creates opportunities for both potential acquisition targets and companies that may pursue similar strategic divestitures to unlock shareholder value.
This group focuses on specialty chemical and industrial companies with strong brand recognition and consistent demand. These businesses often feature infrastructure-like characteristics that make them attractive to private equity and infrastructure funds seeking defensive investments with steady cash flows.
These companies were handpicked by professional analysts based on their potential to benefit from the ongoing divestiture trend. The selection includes both energy majors with chemical divisions that could be spun off and pure-play specialty chemical firms that fit the acquisition target profile.
BP's multi-billion dollar sale of its Castrol lubricants division to an infrastructure firm highlights a strategic shift by energy majors to streamline operations. The investment theme focuses on other specialized chemical and industrial companies that may benefit from similar divestitures or become targets for private capital seeking stable, infrastructure-like assets.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Published on December 27
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
Exxon Mobil
XOM
Current Price
$169.15
This energy major's large chemical and lubricants division is a direct parallel to BP's Castrol, making it a potential candidate for a similar divestm...
This energy major's large chemical and lubricants division is a direct parallel to BP's Castrol, making it a potential candidate for a similar divestment.
Chevron
CVX
Current Price
$217.03
Its Oronite additives subsidiary is a specialized chemical business within a large energy firm, mirroring the Castrol-BP structure and making it a pot...
Its Oronite additives subsidiary is a specialized chemical business within a large energy firm, mirroring the Castrol-BP structure and making it a potential divestiture candidate.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+21.71%
On average, analysts expect assets in this group to grow 21.71% over the next year.
12 of 15 assets in this group are rated Buy by professional analysts.
